Followers | 283 |
Posts | 1162 |
Boards Moderated | 0 |
Alias Born | 10/04/2020 |
Monday, July 19, 2021 12:25:29 AM
Yes, that's yet ANOTHER Multi-Billion Dollar Patent that RGBP has in its 20+ Inventory of Disruptive Biotechnology that will re-define therapeutic approaches for life threatening diseases in the immuno-oncology space!
I noticed that this Patent was assigned to RGBP by the Inventor Dr. Thomas Ichim on March 3, 2015 (scroll to bottom on the following 8K link).
https://www.sec.gov/Archives/edgar/data/1589150/000160706215000089/rgbp20150309form8k.htm
On March 3, 2015 Regen Biopharma, Inc. (“Regen”) entered into an agreement with Dr. Thomas Ichim whereby Dr. Thomas Ichim would sell, assign, transfer and set over to Regen all rights, title and interest in the invention as described and claimed in the United States Patent Number: 8263571 dated September 11, 2011, titled “Gene Silencing of the Brother of the Regulator of Imprinted Sites.” Dr. Thomas Ichim serves as Chief Scientific Officer of Regen Biopharma, and also serves as a member of the Board of Directors.
I'm trying to recall if this is one of the several Patents presently being re-activated since there are several of them listed in the 8K on 7/13/21.
I believe it is:
https://www.otcmarkets.com/filing/conv_pdf?id=15088630&guid=b5Zkkny7De6jVyh
The innovation of this Patent is extraordinary in that it bypasses the standard chemotherapy approach altogether, and instead focuses on "Gene Silencing" of "BORIS" i.e. Brother Of Regulator Imprinted Sites of cancer stem cells, thereby inactivating them.
What this translates to is elimination for the need for chemotherapy in various forms of deadly cancers. Other words curative cancer treatment of a deadly cancer that standard chemotherapy fails in treatment outcome!
Chemotherapy by the way is "Barbaric" in nature and many patients prefer death instead with being made lucid on morphine patches prescribed by their doctor until passing.
This technique and successful outcome of cancer treatment has never been seen before in present day clinical therapeutics. It is therefore futuristic in nature. i.e. The Future of Medicine - RGBP
Thanks
Be well and prosper...
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM